Browsing Cancer Therapeutics by author "O'Brien, Mary"

Now showing items 1-1 of 1

    • Targeting the PD-1/PD-L1 axis in non-small cell lung cancer. 

      Kumar, R; Collins, D; Dolly, S; McDonald, F; O'Brien, MER; et al.
      The last decade has witnessed rapid advances in the discovery and development of immune checkpoint inhibitors in cancer medicine, particularly drugs targeting programmed cell death 1 (PD-1) and programmed cell death ligand ...